Product Owner, Market Access, Access Infinity
Disease Area Head Immunology, Global Payer Strategy, GSK
Head of Marketing, Access Infinity
Artificial intelligence (AI) is everywhere right now. The advent of ChatGPT is shining a spotlight on the possibilities across all industries, with some being quicker to adopt than others.
It’s fair to say that digital adoption within the pharma industry has lagged behind other industries. However, market access has even more catching up to do.
So how should market access approach artificial intelligence? What influence will it have in 2024 and beyond? And what action should market access leaders take to equip their teams to embrace the latest technologies like AI?
In this webinar, recorded on Thursday 25th January, we explore this and more, taking a deeper dive into:
Complete the form and we’ll share a link to the recording.